Clinical implementation of a novel high-throughput screen of primary leukemia cells to customize therapy for relapsed/refractory acute myeloid leukemia (AML) Meeting Abstract


Authors: O'Dwyer, K. M.; Shum, D.; Heaney, M.; Brentjens, R. J.; Maslak, P.; Jurcic, J. G.; Djaballah, H.; Frattini, M. G.
Abstract Title: Clinical implementation of a novel high-throughput screen of primary leukemia cells to customize therapy for relapsed/refractory acute myeloid leukemia (AML)
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 1042
Language: English
ACCESSION: WOS:000272725803212
PROVIDER: wos
PUBMED: 22276299
DOI: 10.1182/blood.V114.22.2657.2657
Notes: Meeting Abstract: 2657 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark L Heaney
    94 Heaney
  2. Renier J Brentjens
    286 Brentjens
  3. Joseph G Jurcic
    134 Jurcic
  4. Peter Maslak
    197 Maslak
  5. Hakim Djaballah
    101 Djaballah
  6. David Shum
    54 Shum
Related MSK Work